Suppression of rat adjuvant arthritis by some acyclic nucleotide analogs.

[1]  J. C. Martin,et al.  Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA). , 1994, Journal of medicinal chemistry.

[2]  F. Bruckner,et al.  Acute arthritis following interferon-alpha therapy. , 1994, British journal of rheumatology.

[3]  S. Nagataki,et al.  Treatment of patients with polyarthritis and anti-HTLV-I antibodies with interferon-alpha. , 1994, Annals of the rheumatic diseases.

[4]  E. De Clercq,et al.  Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates. , 1994, Antiviral research.

[5]  C. Evans,et al.  Nitric oxide and arthritis. , 1993, Arthritis and rheumatism.

[6]  E. Clercq,et al.  Therapeutic potential of HPMPC as an antiviral drug , 1993 .

[7]  T. Pullar,et al.  Cytotoxic therapy in rheumatoid arthritis. , 1993, British journal of rheumatology.

[8]  D. Elleder,et al.  Prevention of acute graft-versus-host disease in rats using 9-(2-phosphonomethoxyethyl) adenine (PMEA). , 1993, Folia biologica.

[9]  V. Křen,et al.  Cytostatic effect of 9-(2-phosphonomethoxyethyl) adenine (PMEA). III. Rat and mouse carcinomas and sarcomas. , 1993, Folia biologica.

[10]  A. Holý,et al.  Synthesis of N-(2-phosphonylmethoxyethyl) derivatives of heterocyclic bases , 1989 .

[11]  A. Holý,et al.  Synthesis of (3-hydroxy-2-phosphonylmethoxypropyl) derivatives of heterocyclic bases , 1989 .

[12]  S. Gilman,et al.  Immunological abnormalities in rats with adjuvant-induced arthritis--II. Effect of antiarthritic therapy on immune function in relation to disease development. , 1987, International journal of immunopharmacology.

[13]  M. Billingham.  Models of arthritis and the search for anti-arthritic drugs. , 1983, Pharmacology & therapeutics.